We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Novel Approach to Vertebral Augmentation Procedures

By HospiMedica International staff writers
Posted on 19 Feb 2014
A new implant-based solution for the treatment of vertebral compression fractures (VCFs) represents a departure from balloon kyphoplasty (BKP), the current standard of care.

The Kiva VCF Treatment System is indicated for use in the reduction and treatment of spinal fractures in the thoracic and/or lumbar spine (T6–L5), providing structural support to the vertebral body and a reservoir to direct and contain bone cement during vertebral augmentation. More...
The system features a flexible implant made from PEEK-OPTIMA, a biocompatible polymer that is widely used and well accepted as a spinal implant. The implant is delivered over a removable guidewire in a continuous loop into the vertebral body through a small diameter, single, percutaneous incision. The amount of the Kiva implant delivered is physician-customized during the procedure.

Both right and left systems are available to enable access to the vertebral body from either pedicle, facilitating directional cement delivery and precluding posterior flow. Design features of the system includes a self-contained deployment handle that requires no preparation; and a nitinol coil (guidewire) that allows for controlled placement within the fractured region of the vertebral body and ensures accurate positioning of the Kiva Implant. The radiopaque implant can be adapted to various fracture morphologies. The Kiva System is a product of Benvenue Medical (Santa Clara, CA, USA).

The Kiva VCF Treatment is intended to be used in combination with the Benvenue Vertebral Augmentation cement kit, which contains highly visible polymethyl methacrylate (PMMA) bone cement and an easy-to-use injection system. The vertebral augmentation kit is designed to simplify the mixing and transferring of the PMMA bone cement with minimal exposure to fumes and to provide precise, controlled delivery of the bone cement, thus maximizing working time and facilitating visualization under fluoroscopy.

“We are excited to bring the Kiva System and its clinical benefits to the large and growing population of VCF patients in the US market,” said Robert Weigle, CEO of Benvenue Medical. “The VCF segment has little Level I clinical data, and we are proud to have sponsored one of the largest randomized studies in this space to date.”

Related Links:

Benvenue Medical



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.